Frequency of the Founder Haplotype (TCGA) in Normal 20210G and Polymorphic 20210A Alleles
Haplotype . | 20210G From Normals . | 20210G From Heterozygotes . | 20210G Combined . | 20210A From Heterozygotes . | 20210*A From Homozygotes . | 20210A Combined . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Int D . | Int E . | Ex 10 . | Int M . | N . | % . | N . | % . | N . | % . | N . | % . | N . | % . | N . | % . |
T | C | G | A | 61 | 27.7 | 57 | 46.3 | 118 | 34.4 | 79 | 64.2 | 15 | 93.8 | 94 | 67.6 |
T | C | G | G | 32 | 14.6 | 22 | 17.9 | 54 | 15.7 | 0 | 0 | 0 | 0 | 0 | 0 |
T | G | G | G | 9 | 4.1 | 0 | 0 | 9 | 2.6 | 0 | 0 | 1 | 6.2 | 1 | 0.7 |
C | G | G | G | 6 | 2.7 | 0 | 0 | 6 | 1.7 | 0 | 0 | 0 | 0 | 0 | 0 |
C | G | A | G | 6 | 2.7 | 0 | 0 | 6 | 1.7 | 0 | 0 | 0 | 0 | 0 | 0 |
C | C | A | G | 2 | 0.9 | 0 | 0 | 2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
T | G | G | A | 2 | 0.9 | 0 | 0 | 2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
Undefined alleles | 102 | 46.4 | 44 | 35.8 | 146 | 42.6 | 44 | 35.8 | 0 | 0 | 44 | 31.7 | |||
Total | 220 | 100 | 123 | 100 | 343 | 100 | 123 | 100 | 16 | 100 | 139 | 100 |
Haplotype . | 20210G From Normals . | 20210G From Heterozygotes . | 20210G Combined . | 20210A From Heterozygotes . | 20210*A From Homozygotes . | 20210A Combined . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Int D . | Int E . | Ex 10 . | Int M . | N . | % . | N . | % . | N . | % . | N . | % . | N . | % . | N . | % . |
T | C | G | A | 61 | 27.7 | 57 | 46.3 | 118 | 34.4 | 79 | 64.2 | 15 | 93.8 | 94 | 67.6 |
T | C | G | G | 32 | 14.6 | 22 | 17.9 | 54 | 15.7 | 0 | 0 | 0 | 0 | 0 | 0 |
T | G | G | G | 9 | 4.1 | 0 | 0 | 9 | 2.6 | 0 | 0 | 1 | 6.2 | 1 | 0.7 |
C | G | G | G | 6 | 2.7 | 0 | 0 | 6 | 1.7 | 0 | 0 | 0 | 0 | 0 | 0 |
C | G | A | G | 6 | 2.7 | 0 | 0 | 6 | 1.7 | 0 | 0 | 0 | 0 | 0 | 0 |
C | C | A | G | 2 | 0.9 | 0 | 0 | 2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
T | G | G | A | 2 | 0.9 | 0 | 0 | 2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
Undefined alleles | 102 | 46.4 | 44 | 35.8 | 146 | 42.6 | 44 | 35.8 | 0 | 0 | 44 | 31.7 | |||
Total | 220 | 100 | 123 | 100 | 343 | 100 | 123 | 100 | 16 | 100 | 139 | 100 |
*In samples of 2 subjects (4 allele), we were unable to amplify the marker in intron D. However, the polymorphisms in intron E, exon 10, and intron M were identical to those of the founder haplotype. Normals consisted of 29 subjects consecutively admitted, 32 referrals for screening of factor II polymorphism, and 49 army personnel. Heterozygotes consisted of 18 subjects identified during screening of consecutive admissions, 103 referrals for screening of factor II polymorphism, and 2 army personnel.